Classification and Personalized Prognosis in Myeloproliferative Neoplasms

Myeloproliferative neoplasms, such as polycythemia vera, essential thrombocythemia, and myelofibrosis, are chronic hematologic cancers with varied progression rates. The genomic characterization of patients with myeloproliferative neoplasms offers the potential for personalized diagnosis, risk stratification, and treatment.We sequenced coding exons from 69 myeloid cancer genes in patients with myeloproliferative neoplasms, comprehensively...